ClinConnect ClinConnect Logo
Search / Trial NCT06879548

Bedside Assessment of Immune Function in Patients With Covid-19

Launched by BARTS & THE LONDON NHS TRUST · Mar 14, 2025

Trial Information

Current as of April 29, 2025

Withdrawn

Keywords

Immune Neutrophil Covid 19

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Over 18y age Suspected diagnosis of Covid-19 Able to give written informed consent
  • Exclusion Criteria:
  • Unwilling or unable to give consent Under 18years of age Suffering from other acute septic/infective illness other than Covid-19

About Barts & The London Nhs Trust

Barts and The London NHS Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality clinical care, research, and education. As a prominent sponsor of clinical trials, the Trust is dedicated to advancing medical knowledge and improving patient outcomes through innovative research initiatives. With a focus on patient safety and ethical standards, Barts and The London NHS Trust collaborates with multidisciplinary teams to explore cutting-edge therapies and interventions across various medical fields, ensuring that trial participants receive the highest level of care and support throughout their involvement.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Colin Hamilton-Davies

Principal Investigator

Barts Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported